Author

Nuria Eugenia Campillo

Centro de Investigaciones Biológicas Margarita SalasORCID 0000-0002-9948-2665Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alicia MansillaiD· 1 shared Carlos Requena-TrigueroiD· 1 shared Celia Miró-Rodríguez· 1 shared Daniel Muñoz-ReyesiD· 1 shared Eugenia UlzurruniD· 1 shared Eulalia Rodríguez‐MartíniD· 1 shared Javier García‐NafríaiD· 1 shared Josep ArgerichiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alicia MansillaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FDA drug repurposing uncovers modulators of dopamine D2 receptor localization via disruption of the NCS-1 interaction

Daniel Muñoz-Reyes, Lorena Aguado, Sandra Arroyo‐Urea, Carlos Requena-Triguero, Sara Pérez-Suárez, Sonia Sánchez-Yepes, Josep Argerich, Celia Miró-Rodríguez, Eugenia Ulzurrun, Eulalia Rodríguez‐Martín, Javier García‐Nafría, Nuria Eugenia Campillo, Alicia Mansilla, María José Sánchez-Barrena

The paper identifies FDA-approved drugs that disrupt the NCS-1/D2R interaction, modulating D2R localization without affecting its signaling.

Journal of Medicinal Chemistry · Nov 10, 2025Peer-reviewedBiochemistry